Global Value-based Healthcare Services Market Size & Forecast:
- Global Value-based Healthcare Services Market Size 2025: USD 1.92 Trillion
- Global Value-based Healthcare Services Market Size 2033: USD 4.143 Trillion
- Global Value-based Healthcare Services Market CAGR: 9.02%
- Global Value-based Healthcare Services Market Segments: By Type (Integrated Care Services, Population Health Management, Pay-for-performance Models, Telehealth Services, AI-based Care Management, Others); By Application (Hospitals, Clinics, Home Healthcare, Insurance Providers, Others); By End-User (Healthcare Providers, Payers, Government Organizations, Patients, Others); By Delivery Mode (Cloud-based, On-premise, Hybrid Platforms, Others)
Global Value-based Healthcare Services Market Summary:
The Global Value-based Healthcare Services Market size is estimated at USD 1.92 trillion in 2025 and is anticipated to reach USD 4.143 trillion by 2033, growing at a CAGR of 9.02% from 2026 to 2033.
The Global Value-based Healthcare Services Market is the restructuring of how providers are paid from units of service to payment based on outcomes, which alters the underlying economics of delivery. The market has transitioned over the last 3-5 years from pilot projects to enterprise deployment and hospital & payer adoption, as the use of digital health systems continues to rise in order to continually monitor patient outcomes. One structural change includes the infusion of AI-enabled analytics into the reimbursement structure, thereby quantifying clinical outcomes for patient populations in real time. Health care provider/payer use of preventative care and coordinated care models, and utilisation of predictive risk tools, remote monitoring and bundled payments are growing financial incentives to prevent hospital readmissions and the rapidly increasing cost of chronic diseases. Since now health care systems benefit from reduced potentially inappropriate interventions and better overall patient long-term health, the continued investment into interoperable data networks and value-based contracts will be incentivised.
Key Global Value-based Healthcare Services Market Insights:
The Global Value-based Healthcare Services Market is transitioning into a data-driven marketplace where reimbursement, clinical delivery, and patient engagement are all optimised on an ongoing basis with real-time outcomes intelligence. The organisations best equipped to deliver a holistic value for end-to-end care are gaining the competitive edge by embedding AI, interoperability, and predictive care into their solutions.
- Hospitals account for 57% of the pie and are now using AI-based outcome dashboards to move away from episodic reporting to ongoing monitoring of performance along care pathways.
- Clinics are gaining 17% share, with digital-first scheduling and EMR-integrated decision tools to help better navigate towards precision outpatient care rather than reactive consultations.
- Home Healthcare accounts for 10% share, with Humana and Signify Health scaling RM programs, and facilitating behavioural change in terms of hospital-at-home and chronic care decentralisation.
- AI-based Care Management is gaining momentum at a rate of 14.1% CAGR and are being integrated into clinical workflows by leading companies such as Optum and Epic Systems, which are using AI to automate risk prediction and prevent avoidable admissions.
- Hybrid Optimizability Behaviour is driving changes to Telehealth Services to incorporate in-person referral networks, Teladoc Health, reflecting post-pandemic stabilisation.
- The use of wearable and IOT health data streams is being used to enable continuous risk scoring with Population Health Management systems, moving from periodic checkups to real-time prevention intervention models.
- The North America region is leading the way in adopting AI, with 42% market share, due to robust payer-provider integration and the enforcement of strict regulations to ensure outcome-based reimbursement models are adhered to.
- Insurers account for 7% of the total, and UnitedHealth Group and Anthem are implementing predictive analytics to shift from static premiums to dynamic risk adjustment, using real-time calculations to model reimbursements.
- Health IT vendors are also consolidating the Integrated Care Service to a digital ecosystem that integrates Telehealth, EHR and analytics, so providers can see the full picture of the patient journey.
What are the Key Drivers, Restraints, and Opportunities in the Global Value-based Healthcare Services Market?
Drivers:
As insurers and government payers adopt fee-for-service and outcome-based reimbursement models to manage rising chronic disease expenses, driver is becoming a key contributor to growth. This change stems from greater penalties for hospital re-admissions and an unsustainable per-capita cost of treatment. This has led to a greater push toward a revenue model based on measurable patient outcomes, which encourages providers to adopt data-driven care models, as well as care coordination and integrated digital health systems, and data platforms. In June 2026, Medbridge launched Medbridge Outcomes. This digital care solution enables physical therapy and rehabilitation organisations to collect, track, and submit patient-reported outcomes, aligning directly with evolving value-based payment models and regulatory reimbursement requirements.
Restraints:
Fragmented healthcare data architecture among providers, payers and diagnostic systems is a key constraint. This is because of legacy EHR systems, which were not built to be interoperable, leading to a lack of clinical coding consistency and measurement of outcomes. This means that many organisations are burdened with steep integration costs and slow ROI when it comes to adopting value-based care models, especially in mid-sized healthcare organisations.
Opportunities:
AI-powered population health orchestration platforms that bring clinical, behavioural, and wearable data together in real-time decision ecosystems are a big future opportunity. For instance, collaborations such as AI diagnostics expansion in Europe and Asia-Pacific health-tech investment hubs are driving up the adoption of predictive care networks. These systems provide the ability to make earlier interventions, lower unnecessary admissions, and provide scalable reimbursement optimisation across entire populations of patients. This is bolstered by digital health funds investing in and hospital–tech partnerships dedicated to longitudinal care management. These changes are likely to have a major impact on margin efficiency and provider involvement with value-based contracts. In February 2026, Verto Health secured 1.52 million in seed funding to expand its AI-powered digital twin platform for population health management. The funding supports automation of administrative workflows, improved care coordination, and enhanced personalised care to strengthen long-term population health outcomes.
What Has the Impact of Artificial Intelligence Been on the Global Value-based Healthcare Services Market?
AI is being applied to the Global Value-based Healthcare Services Market to enable continual improvement in the delivery, costs, and outcomes of patient care. Within value-based models, AI is typically applied in the areas of automation of administrative and clinical workflows, including claims processing, patient risk stratification, and care coordination, to decrease the manual error rates and operational delays. Use of predictive analytic models has been extended, and they are employed to effectively risk-stratify patients, allowing for earlier interventions and subsequent decreased hospital readmission rates. Operationally, decision support tools can optimise care pathways to be synchronised with outcomes tied to reimbursement, improving clinical standardisation and financial performance. Real-time data feeds from sources like wearable devices, electronic health records, and remote monitoring solutions also augment patient populations with more up-to-date performance statistics across multiple care networks and facilitate population health management.
In addition, integration and data accuracy are persistent limitations, as a lack of cohesive system architecture and inconsistent clinical codes in data systems diminishes model accuracy, thus increasing provider costs and implementation times for small and medium-sized organisations. Overall, AI is emerging as a fundamental driver of value-based care transformation across the world that improves both efficiency and patient satisfaction levels across many networks over time. In May 2026, Roche agreed to acquire PathAI. This acquisition expands AI-powered diagnostics capabilities, strengthening predictive pathology and clinical decision support systems that enhance precision medicine and support value-based reimbursement models.
Key Global Value-based Healthcare Services Market Trends:
The Global Value-based Healthcare Services Market is undergoing a dynamic shift from the pilot to the AI era of real-time outcome-based payment and care ecosystems, where payment, delivery and analytics are becoming a seamless whole. Under the best scenarios, it is not growth itself that is shifting, but the redefinition of the value of healthcare, how it is measured and how it is put into practice within digital-first care networks.
- Outcome measures moving from subjectivity to objectivity – Outcome measures are shifting from subjective to objective and from static to AI-driven.
- Empower patients to take charge – Behavioural demand for a continuous care experience is creating a shift from provider-centric to patient-journey ecosystems.
- Shift from reactive to proactive reimbursement – Organizations are increasingly shifting to preventative payment models and saving on costly interventions before they occur using risk prediction models.
- Focus on data post-processing – Performance incentives are shifting from individual data to a focus on data post-processing.
- Interoperability stress driving mergers and platforms – Dispersed health IT systems are being consolidated or replaced by a single, unified data ecosystem to track values consistently.
- Rise in transparency expectations – There is a growing patient and payer expectation of transparency to allow them to choose providers based on published outcomes and cost-effectiveness data.
- AI governance norms in clinical care trajectories – Regulations and ethics are permeating the pathways of clinical care that involve AI.
- Move beyond pilot to system implementation – Value-based care is becoming more than just a pilot – it is a mandatory implementation of the system by insurers and provider networks.
Global Value-based Healthcare Services Market Segmentation
By Type:
The Integrated Care Services and Population Health Management are now the pillars upon which the Global Value-based Healthcare Services Market is building itself, given the industry’s shift away from a fractured and treatment-focused model to a linked-together and outcomes-based ecosystem. Payment for Performance, which drives the reimbursement system to conform to outcomes, will keep on strengthening, with telehealth services also seeing increasing adoption from continuous infrastructure investment. With AI-driven risk stratification capabilities and optimised clinical decision pathways being the main driving force, AI-based Care Management will have the largest CAGR of 14.1%, with a futuristic role that would see fully self-governed care orchestration mechanisms adjust treatments in real-time based on continuous patient data.
By Applications:
Hospitals maintain a majority market share at 57% due to their continuing role as the centre for complex care delivery and linked performance measurements with reimbursement. Clinics capture 17% market share thanks to outpatient digitisation trends, and Home Healthcare 10% is growing on the back of an ageing demographic and remote monitoring proliferation. Insurance Providers capture 7% market share while growing rapidly through their use of analytics for claims optimisation and risk pooling. Others capture 9% and consist of new digital care delivery platforms. The central growth logic of the market is a move toward distributed care delivery models, pushing value-based measurement beyond the walls of hospitals.
By End-User:
Healthcare providers are the main adopters due to direct revenue stream incentives, while payers aim at cost reduction through prediction and bundled payments. Government organisations are increasingly promoting adoption in a policy-driven fashion, while patients are impacting demand indirectly through consumerism. Other actors support adoption through niche implementations.
By Delivery Mode:
The Cloud model is expanding significantly due to its scalability and real-time data capabilities; the Hybrid model also seems to be on the rise as vendors start to transition from traditional to modern infrastructure. While the on-premise model remains to be used within the regulated environment, it has started to diminish as the need for interoperability across the worldwide healthcare sector increases.
What are the Key Use Cases Driving the Global Value-based Healthcare Services Market?
Chronic disease management-The most prominent use-case linked to the primary care segment is driving improved diabetes management (via blood sugar control), post-surgery readmission reduction, and positive reinforcement for ongoing monitoring rather than repeated hospital admissions.
The remote monitoring of heart failure, COPD, and hypertension is being folded into 2026 value-based contracts; telehealth to provide remote visits and medication compliance monitoring. Medicaid value-based care has become the fastest growth segment, being extended beyond primary care to specialist segments of behavioural health, oncology, maternity care, etc.
AI ambient documentation and automated prior authorisation to relieve the administration, digital therapeutics for chronic disease prevention in a CMS Innovation Centre's ACCESS model and AI platforms for contract adjudication, like the 58 arbitrations completed in 3 months using Arbital Health's neutral third-party system.
|
Report Metrics |
Details |
|
Market size value in 2025 |
USD 1.92 Trillion |
|
Market size value in 2026 |
USD 2.263 Trillion |
|
Revenue forecast in 2033 |
USD 4.143 Trillion |
|
Growth rate |
CAGR of 9.02% from 2026 to 2033 |
|
Base year |
2025 |
|
Historical data |
2021 - 2024 |
|
Forecast period |
2026 - 2033 |
|
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
|
Regional scope |
United States; Canada; Mexico; United Kingdom; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; United Arab Emirates |
|
Key company profiled |
UnitedHealth Group, CVS Health, Humana, Cerner, Athenahealth, Epic Systems, McKesson, Optum, Philips Healthcare, Siemens Healthineers, Oracle Health, IBM Watson Health, eClinicalWorks, GE Healthcare, Medtronic. |
|
Customization scope |
Free report customisation (country, regional & segment scope). Avail customised purchase options to meet your exact research needs. |
|
Report Segmentation |
By Type (Integrated Care Services, Population Health Management, Pay-for-performance Models, Telehealth Services, AI-based Care Management, Others); By Application (Hospitals, Clinics, Home Healthcare, Insurance Providers, Others); By End-User (Healthcare Providers, Payers, Government Organizations, Patients, Others); By Delivery Mode (Cloud-based, On-premise, Hybrid Platforms, Others). |
Which Regions are Driving the Global Value-based Healthcare Services Market Growth?
The North American market leads the Global Value-based Healthcare Services Market with a 42% share, due to robust reimbursement reform and digital health infrastructure. In this region, the advanced policy infrastructure includes Medicare value-based purchasing programs that directly tie physician payment to patient outcomes, leading to wide-scale AI-enabled analytics adoption, integrated EHR and large-scale payer-provider collaboration. Moreover, high demand for reducing the burden of chronic diseases also speeds up the adoption of outcome-based models at an enterprise level. In February 2026, Quantum Health partnered with Lantern to expand access to value-based speciality care, integrating bundled surgical services into its platform to reduce costs and improve outcomes for self-funded employers in North America.
Europe holds around 28% market share and demonstrates steady adoption driven by centralised healthcare systems and government-led quality benchmarking initiatives. Unlike North America’s payer-driven model, Europe’s growth is supported by regulatory harmonisation and national health service modernisation programs. Stability is reinforced through universal healthcare coverage, which enables the structured rollout of bundled payment and population health programs across multiple countries. However, slower digital infrastructure standardisation slightly limits the speed of advanced AI integration compared to North America. In January 2026, the UK NHS launched its 10-Year Health Plan, standardizing value-based procurement and shifting about 10 billion in MedTech spending toward outcome-based purchasing tied to measurable patient outcomes.
The region Asia Pacific is the fastest-growing market with a CAGR of 13.5%. Driven by the swift adoption of digital healthcare and rising health expenditure across developing countries, recently post-pandemic healthcare reforms have accelerated the adoption of Telehealth, Digital Insurance portals, and AI-driven hospital management systems. The greatest unmet demand in cost-effective care delivery provides a huge opportunity, prompting governments as well as private players to leverage scalable value-based care ecosystems. Health tech investment and hospital upgrades will fuel the rapid uptake of outcome-based payment models. In April 2026, Hims & Hers acquired Australia’s Eucalyptus for up to 1.15 billion. The acquisition integrates a leading direct-to-consumer digital health platform into its global operations, accelerating scalable, data-driven remote care and outcome-based digital healthcare delivery across the Asia-Pacific region.
Who are the Key Players in the Global Value-based Healthcare Services Market and how do they Compete?
The Global Value-based Healthcare Services Market is characterised by strong competition from integrated payviders, technology platforms, and pharmacy benefit managers. Major players include UnitedHealth Group (Optum), Humana, CVS Health (Aetna), Elevance Health, and Cigna, in addition to technology platforms from Oracle Health, Epic Systems and McKesson, all participating in a multi-faceted market where payers integrate with providers and tech vendors to enable outcome-based care.
UnitedHealth Group operates an innovation strategy through its payvider ecosystem by coupling UnitedHealthcare's insurance plan with Optum's data analytics and care delivery, and currently covers 4.7M patients with value-based arrangements – a twofold increase in three years; it plans to expand with the unified infrastructure across its geography. CVS Health adopts an innovation strategy by acquiring primary care platforms, such as Street Health, at 10.6B, with a focus on integrated pharmacy-primary care and access for underserved populations; Humana focuses on Medicare Advantage with a niche strategy for integration of whole-person care, expansion by invitation only, but withdraws from MA from 95% of US counties to 85% in 2026 under reimbursement pressure. Epic Systems and Oracle Health compete using a cost-leadership strategy for EHR technology that enables interoperability and data analytics to support value-based arrangements, while McKesson relies on supply chain scale for cost benefits; Philips Healthcare and Siemens Healthineers focus on niche diagnostic and imaging segments. These players expand by leveraging strategic partnerships, penetrating geographies, and using AI-powered clinical decision support tools in order to take part in value-based care.
Key Players are :
- UnitedHealth Group
- CVS Health
- Humana
- Cerner
- athenahealth
- Epic Systems
- McKesson
- Optum
- Philips Healthcare
- Siemens Healthineers
- Oracle Health
- IBM Watson Health
- eClinicalWorks
- GE HealthCare
- Medtronic
Recent Development News
- In February 2026, Aledade added a record 700 new primary care organisations to its value-based care network, bringing total partners to over 3,000 practices serving 3 million patients, demonstrating strong demand for platforms enabling independent practices to succeed in risk models.
https://briefglance.com/companies/aledade-inc
- In February 2026, CenterWell Senior Primary Care completed the acquisition of MAXhealth. This strategic transaction integrates MAXhealth’s 54 primary care clinics and 24 affiliated clinics into CenterWell's operations, expanding its value-based care delivery to over 120,000 patients across Florida.
- In January 2026, the Centres for Medicare & Medicaid Services (CMS) launched the Transforming Episode Accountability Model (TEAM). This mandatory initiative upgrades surgical reimbursement across 741 acute care hospitals by replacing fractured, multi-provider bills with a single bundled payment covering the entire surgical episode from admission through 30 days post-discharge to force care coordination.
https://institute4ac.org/team-resources/
What Strategic Insights Define the Future of the Global Value-based Healthcare Services Market?
The Global Value-based Healthcare Services Market is transforming from a service-centric model to an AI-powered, outcome-based ecosystem where payments will be linked more closely to long-term patient outcomes and less to the number of services rendered. An emerging threat is poor digital health interoperability that may compromise outcome accuracy and encourage fraudulent reporting. Conversely, there are tremendous opportunities within predictive analytics and real-time patient monitoring platforms to enable proactive treatment interventions and value maximisation on a population-wide scale. To succeed in this space, stakeholders must prioritise the establishment of an integrated data infrastructure, development of interoperability standards and adoption of AI governance to facilitate value delivery transparency, measurability and scalability; transformation of providers will be pivotal for establishing a competitive advantage and matching clinical outcomes with financial sustainability. Early-adopting providers who invest in interoperable platforms and AI-enhanced decision support systems will gain optimal reimbursement efficiency and higher patient loyalty in the long run, provided that they do not neglect ethical transparency and bias mitigation within their algorithmic care models to ensure regulatory confidence globally and locally.
Key Segmentations are:
By Type
- Integrated Care Services
- Population Health Management
- Pay-for-performance Models
- Telehealth Services
- AI-based Care Management
- Others
By Application
- Hospitals
- Clinics
- Home Healthcare
- Insurance Providers
- Others
By End-User
- Healthcare Providers
- Payers
- Government Organizations
- Patients
- Others
By Delivery Mode
- Cloud-based
- On-premise
- Hybrid Platforms
- Others
Regional Outlook
North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- Japan
- China
- Australia & New Zealand
- South Korea
- India
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Rest of South America
Middle East & Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of the Middle East & Africa
Frequently Asked Questions
Find quick answers to common questions.
The Global Value-based Healthcare Services Market size was valued at USD 1.92 trillion in 2025 and is poised to reach USD 4.143 trillion by 2033, expanding at a 9.02% CAGR.
Key segments for the Global Value-based Healthcare Services Market are By Type (Integrated Care Services, Population Health Management, Pay-for-performance Models, Telehealth Services, AI-based Care Management, Others); By Application (Hospitals, Clinics, Home Healthcare, Insurance Providers, Others); By End-User (Healthcare Providers, Payers, Government Organizations, Patients, Others); By Delivery Mode (Cloud-based, On-premise, Hybrid Platforms, Others).
Growth is driven by the shift to outcome-based reimbursement models aimed at controlling chronic disease costs, triggered by rising readmission penalties and high treatment expenses, accelerating adoption of data-driven care and digital health systems, as seen in June 2026 when Medbridge launched Medbridge Outcomes to support patient-reported outcome tracking aligned with value-based reimbursement.
The Global Value-based Healthcare Services Market is led by major manufacturers, including UnitedHealth Group, CVS Health, Humana, Cerner, Athenahealth, Epic Systems, McKesson, Optum, Philips Healthcare, Siemens Healthineers, Oracle Health, IBM Watson Health, eClinicalWorks, GE Healthcare, and Medtronic.
North America, with a 42% market share, influences global dynamics through advanced payer–provider integration, strong value-based reimbursement policies, and rapid AI adoption that sets benchmarks for outcome-driven healthcare delivery systems worldwide.
Commercial opportunities are emerging in AI-powered population health platforms integrating clinical and wearable data for real-time decisions, supported by rising digital health investments and partnerships, to expand their digital twin platform for improving care coordination and outcomes.
- UnitedHealth Group
- CVS Health
- Humana
- Cerner
- athenahealth
- Epic Systems
- McKesson
- Optum
- Philips Healthcare
- Siemens Healthineers
- Oracle Health
- IBM Watson Health
- eClinicalWorks
- GE HealthCare
- Medtronic
Recently Published Reports
-
Apr 2026
AI in Diabetic Retinopathy Market
AI in Diabetic Retinopathy Market Size, Share & Analysis Report By Type (Screening AI Systems, Diagnostic AI Systems, and Predictive AI Models), By Application Segment (Hospitals, Ophthalmology Clinics, Diagnostic Centers, and Research and Development), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 - 2031
-
Apr 2026
Psychometric Tests Market
Psychometric Tests Market Size, Share & Analysis Report By Type (Personality Tests, Ability/Aptitude Tests, Skill/Knowledge Tests, and Others), By Application (Talent Acquisition and Talent Management), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
-
Apr 2026
Rare Biological Sample Collection Market
Rare Biological Sample Collection Market Size, Share & Analysis Report By Type (Isolation Kits & Reagent, Blood Collection Tubes, and Others), By Application (Oncology, Transcriptomics, Pharmacogenomics, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
-
Jul 2026
Diabetic Retinopathy Market
Diabetic Retinopathy Market Size, Share & Analysis Report By Type (Proliferative Diabetic Retinopathy, and Diabetic Macular Edema (DME)), By Treatment Type (Anti VEGF Drug, Steroid Implants, Laser Surgeries, and Vitrectomy), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
Our Clients
.jpg)









